# Idexx Laboratories Inc: filings

IDXX · Nasdaq · CIK 874716 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/idxx.md) · [Financials](/companies/idxx/financials.md) · [Filings](/companies/idxx/filings.md) · [Insiders](/companies/idxx/insiders.md)

## Reports and events: 245 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1005, 8-K 150, SC 13G/A 79, 10-Q 53, 144 42, 3 33, 10-K 18, DEF 14A 18, DEFA14A 18, CT ORDER 14, SC 13G 13, SD 13, 4/A 12, UPLOAD 12, ARS 11, CORRESP 9, 5 6, 8-K/A 6, S-8 4, 3/A 3, PRE 14A 2, S-8 POS 2, SCHEDULE 13G 2, SCHEDULE 13G/A 2, 5/A 1, DEFR14A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-04 | 16:16 ET | [10-Q](/filings/0000874716-26-000123.md) | Quarterly report, period 2026-06-30 | 0000874716-26-000123 |
| 2026-08-04 | 06:32 ET | [8-K](/filings/0001104659-26-090033.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-090033 |
| 2026-05-15 | 16:00 ET | [8-K](/filings/0000874716-26-000110.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000874716-26-000110 |
| 2026-05-05 | 16:14 ET | [10-Q](/filings/0000874716-26-000076.md) | Quarterly report, period 2026-03-31 | 0000874716-26-000076 |
| 2026-05-05 | 06:31 ET | [8-K](/filings/0001104659-26-055203.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-055203 |
| 2026-03-27 | 16:00 ET | [DEF 14A](/filings/0000874716-26-000064.md) | Proxy statement, period 2025-12-31 | 0000874716-26-000064 |
| 2026-03-26 | 08:30 ET | [8-K](/filings/0001104659-26-034906.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-034906 |
| 2026-02-20 | 16:09 ET | [10-K](/filings/0000874716-26-000038.md) | Annual report, period 2025-12-31 | 0000874716-26-000038 |
| 2026-02-13 | 17:00 ET | [8-K](/filings/0000874716-26-000007.md) | 5.02 Departure or appointment of officers or directors | 0000874716-26-000007 |
| 2026-02-02 | 06:39 ET | [8-K](/filings/0001104659-26-008904.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-008904 |
| 2026-01-13 | 08:33 ET | [8-K](/filings/0001104659-26-003103.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-003103 |
| 2025-11-13 | 16:07 ET | [8-K](/filings/0001104659-25-111278.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-25-111278 |
| 2025-11-03 | 16:13 ET | [10-Q](/filings/0000874716-25-000165.md) | Quarterly report, period 2025-09-30 | 0000874716-25-000165 |
| 2025-11-03 | 06:34 ET | [8-K](/filings/0001104659-25-105185.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-105185 |
| 2025-10-07 | 07:06 ET | [8-K](/filings/0001104659-25-097319.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-097319 |
| 2025-08-04 | 16:22 ET | [10-Q](/filings/0000874716-25-000121.md) | Quarterly report, period 2025-06-30 | 0000874716-25-000121 |
| 2025-08-04 | 06:30 ET | [8-K](/filings/0001104659-25-073304.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-073304 |
| 2025-07-10 | 07:00 ET | [8-K](/filings/0001104659-25-066840.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-066840 |
| 2025-05-09 | 16:00 ET | [8-K](/filings/0000874716-25-000085.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000874716-25-000085 |
| 2025-05-01 | 16:11 ET | [10-Q](/filings/0000874716-25-000062.md) | Quarterly report, period 2025-03-31 | 0000874716-25-000062 |
| 2025-05-01 | 06:30 ET | [8-K](/filings/0001104659-25-042955.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-042955 |
| 2025-03-28 | 16:00 ET | [DEF 14A](/filings/0000874716-25-000054.md) | Proxy statement, period 2024-12-31 | 0000874716-25-000054 |
| 2025-02-21 | 08:28 ET | [10-K](/filings/0000874716-25-000037.md) | Annual report, period 2024-12-31 | 0000874716-25-000037 |
| 2025-02-14 | 16:00 ET | [8-K](/filings/0000874716-25-000011.md) | 5.02 Departure or appointment of officers or directors | 0000874716-25-000011 |
| 2025-02-03 | 06:30 ET | [8-K](/filings/0001104659-25-008331.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-008331 |
| 2024-12-12 | 16:00 ET | [8-K](/filings/0000874716-24-000150.md) | 5.02 Departure or appointment of officers or directors | 0000874716-24-000150 |
| 2024-12-09 | 07:32 ET | [8-K](/filings/0000874716-24-000148.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000874716-24-000148 |
| 2024-11-21 | 07:32 ET | [8-K](/filings/0001104659-24-121326.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-121326 |
| 2024-11-12 | 07:30 ET | [8-K](/filings/0001104659-24-116365.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-116365 |
| 2024-11-06 | 16:00 ET | [8-K](/filings/0000874716-24-000142.md) | 1.01 Entry into a material agreement | 0000874716-24-000142 |
| 2024-10-31 | 16:14 ET | [10-Q](/filings/0000874716-24-000139.md) | Quarterly report, period 2024-09-30 | 0000874716-24-000139 |
| 2024-10-31 | 13:23 ET | [8-K/A](/filings/0001104659-24-112975.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-112975 |
| 2024-10-31 | 06:30 ET | [8-K](/filings/0001104659-24-112826.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-112826 |
| 2024-08-06 | 16:07 ET | [10-Q](/filings/0000874716-24-000121.md) | Quarterly report, period 2024-06-30 | 0000874716-24-000121 |
| 2024-08-06 | 06:30 ET | [8-K](/filings/0001104659-24-086074.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-086074 |
| 2024-05-10 | 16:00 ET | [8-K](/filings/0000874716-24-000107.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000874716-24-000107 |
| 2024-05-01 | 16:13 ET | [10-Q](/filings/0000874716-24-000083.md) | Quarterly report, period 2024-03-31 | 0000874716-24-000083 |
| 2024-05-01 | 06:30 ET | [8-K](/filings/0001104659-24-055201.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-055201 |
| 2024-03-27 | 16:00 ET | [DEF 14A](/filings/0000874716-24-000075.md) | Proxy statement, period 2023-12-31 | 0000874716-24-000075 |
| 2024-02-22 | 16:17 ET | [10-K](/filings/0000874716-24-000057.md) | Annual report, period 2023-12-31 | 0000874716-24-000057 |
| 2024-02-05 | 06:30 ET | [8-K](/filings/0001157523-24-000165.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-24-000165 |
| 2023-12-07 | 16:05 ET | [8-K](/filings/0000874716-23-000143.md) | 5.02 Departure or appointment of officers or directors | 0000874716-23-000143 |
| 2023-11-01 | 16:20 ET | [10-Q](/filings/0000874716-23-000128.md) | Quarterly report, period 2023-09-30 | 0000874716-23-000128 |
| 2023-11-01 | 06:30 ET | [8-K](/filings/0001157523-23-001588.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-23-001588 |
| 2023-08-01 | 16:08 ET | [10-Q](/filings/0000874716-23-000100.md) | Quarterly report, period 2023-06-30 | 0000874716-23-000100 |
| 2023-08-01 | 06:30 ET | [8-K](/filings/0001157523-23-001198.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-23-001198 |
| 2023-07-12 | 07:01 ET | [8-K](/filings/0000874716-23-000092.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000874716-23-000092 |
| 2023-05-19 | 16:00 ET | [8-K](/filings/0000874716-23-000074.md) | 5.07 Shareholder vote results | 0000874716-23-000074 |
| 2023-05-02 | 16:02 ET | [10-Q](/filings/0000874716-23-000034.md) | Quarterly report, period 2023-03-31 | 0000874716-23-000034 |
| 2023-05-02 | 06:34 ET | [8-K](/filings/0001157523-23-000670.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-23-000670 |

Page 1 of 5. [Older](/companies/idxx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 13:55 ET. No prices; not investment advice.